Research from Mayo Clinic and UCSF find that the combination of Transpara ® Exam Score with Volpara TruDensity® can predict long-term risk of invasive breast cancers NIJMEGEN, Netherlands
Volpara Health Technologies Ltd. has announced an expanded sponsorship of DenseBreast-info.org (DBI). The global provider of artificial intelligence (AI) software for early cancer detection will donate 5% of the profits from all sales of its Volpara Scorecard breast density assessment software to DBI for the next twelve months. The formal announcement will take place during the Society of Breast Imaging (SBI) 2023 Symposium.
Breast cancer screening innovator named Wellingtonian of the Year stuff.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuff.co.nz Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection of cancer, is attending this year s National.